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Abstract
Background: Patients with COPD on long term oxygen therapy frequently do not adhere to their prescription, and
they frequently do not use their ambulatory oxygen systems as intended. Reasons for this lack of adherence are
not known. The aim of this study was to obtain in-depth information about perceptions and use of prescribed
ambulatory oxygen systems from patients with COPD to inform ambulatory oxygen design, prescription and
management.
Methods: A qualitative design was used, involving semi-structured face-to-face interviews informed by a grounded
theory approach. Twenty-seven UK community-dwelling COPD patients using NHS prescribed ambulatory systems
were recruited. Ambulatory oxygen systems comprised cylinders weighing 3.4 kg, a shoulder bag and nasal
cannulae.
Results: Participants reported that they: received no instruction on how to use ambulatory oxygen; were uncertain
of the benefits; were afraid the system would run out while they were using it (due to lack of confidence in the
cylinder gauge); were embarrassed at being seen with the system in public; and were unable to carry the system
because of the cylinder weight. The essential role of carers was also highlighted, as participants with no immediate
carers did not use ambulatory oxygen outside the house.
Conclusions: These participants highlighted previously unreported problems that prevented them from using
ambulatory oxygen as prescribed. Our novel findings point to: concerns with the lack of specific information
provision; the perceived unreliability of the oxygen system; important carer issues surrounding managing and using
ambulatory oxygen equipment. All of these issues, as well as previously reported problems with system weight and
patient embarrassment, should be addressed to improve adherence to ambulatory oxygen prescription and
enhance the physical and social benefits of maintaining mobility in this patient group. Increased user involvement
in both system development and service provision planning, could have avoided many of the difficulties
highlighted by this study.
Background
The need for user involvement in healthcare research is
now well established in the UK National Health Service
(NHS) [1]. This concept is also becoming more com-
mon in new medical device development through pro-
jects such as the Multidisciplinary Assessment of
Technology Centre for Healthcare (MATCH) [2].
However, many devices currently in use within the NHS
were designed prior to the introduction of this concept,
including oxygen delivery systems. This paper explores
reasons for non-use of a specific health technology and
highlights the necessity for research to tease out the
needs of patients and involve them in designing new
devices and systems.
Ambulatory oxygen (AO) provides a way to allow
patients with severe COPD to continue to remain active
within their community, maintaining exercise tolerance
and social interaction. In the UK, AO became widely
available for prescription in 2006 [3]. Under British
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Thoracic Society guidelines prescription of AO for
patients with COPD should follow specific criteria either
as an addition to long-term oxygen therapy (LTOT) or
for exercise desaturation in patients who are normoxic
at rest. However, in some regions of the UK patients
continue to be prescribed LTOT and AO by a General
Practitioner (GP), or after discharge from hospital, with
no formal assessments and no follow-up. It is known
that patients with COPD frequently fail to adhere to
their oxygen prescription [4]. A trial specifically investi-
gating the use of AO [5] was prematurely ended because
participants were not using their AO systems. This
situation is clearly wasteful of health resources.
Adherence to prescribed medication is known to be
fundamental to optimising the management of long-term
conditions [6]. However, despite recent improvements in
COPD management, high levels of non-adherence
remain and have been shown to be predominantly influ-
enced by patient beliefs, behaviours and experiences [7].
Croxton and Bailey have suggested that the underuse of
AO, and the reasons for this underuse, need further
research [8]. These authors also advocate research to
clarify the benefits of AO, and the way that patients with
COPD use AO, as a priority for medical researchers. This
call for more research into the use of AO has been
echoed by others, including the 2010 Department of
Health consultation document on COPD services in Eng-
land [9-12]. Albert and Calverley have suggested that
whatever clinical benefits patients with COPD may derive
from using AO, what remains largely unknown is how
these patients use AO in their day to day lives [11].
There is little published evidence on why COPD
patients choose to use their AO cylinders or not. With-
out this information it will be difficult to support
patients who may have difficulty using AO, and ensure
that active patients receive optimal levels of AO. This
qualitative study therefore aimed to explore patients’ use
of AO, by asking patients with COPD who had already
been prescribed AO, to identify and describe what influ-
enced their use of their AO system within the
community.
Methods
The objective of this study was to gain information from
patients themselves. A questionnaire approach was
rejected because it was important to understand the rea-
sons patients had for using or not using their AO and
the perceptions underlying this behaviour. Therefore an
inductive qualitative methodology was employed using a
semi-structured interview guide. Grounded Theory (GT)
was chosen as the methodological approach because GT
aims to produce theory about the area under study [13].
GT as described by Glaser and Strauss in 1967, uses a
method of constant comparative analysis for analysing
qualitative data to produce relevant social theory induc-
tively [14]. Each interview is transcribed and analysed
before the next interview so that areas of interest which
have been voiced by previous participants can be
explored further. As a study continues, more specific
participants are recruited to the study to strengthen or
refute any emergent theories, such as differences in per-
ceptions of participants with or without carers, living in
a family or living alone. This study was underpinned by
an objectivist philosophy and placed the researcher as a
detached collector of objective data. The GT approach
in this study was adapted from its purest form because
some of the tenets of the original approach (no prior
knowledge; theoretical sampling) are incompatible with
conducting ethical NHS research. A literature search
preceded Ethical submission for this study, and the
semi-structured questionnaire was based partly on this
literature search and partly on researchers’ clinical
experience. In line with a GT approach, further litera-
ture searches occurred as theory began to emerge induc-
tively from the study findings. This study also involved
second interviews approximately one year after the ori-
ginal interviews (with a sample of the original partici-
pants) to ensure the study results accurately reflected
the views of the participants; this acted as a means to
increase the validation and credibility of the reported
results. Full ethical approval was obtained from the
Local Research Ethics Committee (Isle of Wight, Ports-
mouth and South East Hampshire REC 06/Q1701/61)
prior to recruitment.
Recruitment and sampling
Inclusion criteria
• Patients registered at the Respiratory Centre, Ports-
mouth, UK
• Documented diagnosis of COPD
• Prescription for ambulatory oxygen
Exclusion criteria
• Additional co-morbidities that may have affected
oxygen usage
• Inability to take part in interviews due to cognitive
or language difficulties
• Living outside the area covered by the Local
Research Ethics Committee
• Recent (within three months of interview) admis-
sion to hospital
Patients who met the inclusion criteria were identified
by a respiratory nurse from a register at the Respiratory
Centre responsible for oxygen assessments. Potential
participants were posted an invitation letter by the
nurse and asked to reply if they wished to be included
in the study. In line with qualitative interviewing princi-
ples, as wide a variety of individuals as possible were
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approached for recruitment (that is, purposive sampling
was used to gain a diversity of opinion), irrespective of
age, gender, living arrangements or length of time with
AO prescription. Forty-four invitations were posted,
from which 34 responded positively. One of these died
prior to interview, two decided not to be interviewed,
and five were excluded for not meeting the entry
criteria.
Interviews
Twenty-seven individuals with COPD agreed to be inter-
viewed in their own homes, where written informed con-
sent was obtained. The researcher used a semi-structured
interview topic guide (see Additional file 1). This was
initially devised from the researcher’s clinical experience,
but transcripts were analysed after each interview (prior
to the next interview). This enabled the researcher to
alter the topic guide to incorporate themes as they
emerged and use them at subsequent interviews. This
process continued until saturation was reached and no
new information was forthcoming. In line with the objec-
tivist GT approach to this study, the interviewer
attempted to remain detached from interaction with the
participant during the interview process, apart from
encouraging the participant to expand on answers and to
clarify any unclear statements. All interviews were audio-
taped with permission. Carers were frequently present
during interviews and their comments were recorded and
included with permission. Respondent validation inter-
views took place from six to 12 months after the initial
interviews, with seven of the original participants (repre-
senting 33% of those still alive).
Data Analysis
All interview recordings were transcribed and anon-
ymised by one of the authors (EA). The transcripts were
analysed initially using open coding where each line of
the transcript was analysed to identify data pertinent to
the research question and relevant data were recorded
under a heading or code. Open codes were compared
for similarities and differences using constant compara-
tive analysis, and links between codes and categories
formed. Information derived from early participants was
used to frame areas for discussion with subsequent par-
ticipants. New information relating to the lack of infor-
mation available, fear of running out, and carer support
was derived in this way. Possible emergent theory,
derived by examining categories, was established by
using ‘common sense’ linkages within the data. Negative
cases (views expressed that differed from the majority)
were also identified. Data collection continued until no
new findings emerged from the data analysis and satura-
tion was deemed to have occurred. Extensive memo
writing accompanied all stages of the analysis. A second
experienced qualitative researcher independently pro-
duced codes for a sample of the participants, to verify
the analysis procedure. No divergence in the two ana-
lyses was found, although the second analyser suggested
additional areas of coding and emphasised supporting or
conflicting data, or areas needing more investigation
during the interviews. The subsequent respondent vali-
dation interviews with participants supported the origi-
nal data, emergent coding and main findings of the
study.
Results
Of the 27 participants, 14 were male (50%) and 24 were
over 60 years of age (88%). The average age was 68
years, with a range from 54 to 85 years. No formal test-
ing of clinical status was undertaken as it was not rele-
vant to the research question. Twenty-three (85%)
participants were married with their spouse as the pri-
mary carer. Four (15%) lived alone and relied on rela-
tives, who lived some distance away, for any support.
Transport: Seven (26%) of the 27 participants had given
up driving and were reliant on electric buggies to take
them to the local shops or to appointments; four (15%)
did not have any personal transport available to them;
one used a motorcycle; and the remaining 16 (59%) had
access to a car. Oxygen: Two of the participants (7%)
did not qualify for long term oxygen therapy (LTOT)
and had stand alone AO cylinders; eleven (41%) already
used LTOT before being prescribed AO; the remaining
14 (52%) received both LTOT and AO together. All par-
ticipants were prescribed an oxygen cylinder weighing
3.4 kg which was delivered with a shoulder bag to allow
the patient to carry the cylinder. All participants had
their AO cylinders delivered by the local provider and
used nasal cannulae to interface with the AO system.
Main findings
The main barriers to AO use were strongly felt by most of
the participants, so that codes were saturated very quickly
for those areas. The subsequent respondent validation
interviews supported the original data and emergent cod-
ing. The selected quotations have been chosen as the
words or phrases which best represent (in the researchers’
opinion) all the patients’ views in the domain described.
Negative cases are described after the majority view has
been expressed.
The participant (Pt) number, the page and line of the
transcript are in brackets after each quotation. Carer
comments are identified as ‘Carer’.
1. Lack of information: confusion around AO use
Twenty-five participants could not recall receiving any
information on the use of their AO system from a health-
care professional. The two who could recall such infor-
mation had received their AO from their Respiratory
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Centre. No-one who had received AO as part of a dis-
charge package from their local general hospital or from
their GP, reported receiving any AO instructions from
professionals.
“They wouldn’t let me home (from hospital) until that
concentrator was installed and that (AO) came with it.
We got a booklet for the concentrator but the guy who
brought it (AO) told me to turn it on to two litres a
minute, he said turn it to that so that’s how we use it.”
(Pt5, 5, 145)
“I asked for it (AO) and got it through the GP, I was
very breathless when I went out of the house and
couldn’t cope so I asked him for it, but that was it, I
don’t remember any instructions just use it when I felt I
needed it and that was on an ad hoc basis.” (Pt1, 3, 71)
There were no negative cases reported in this domain.
2. Lack of benefit: the AO system makes no difference
Thirteen participants described perceiving a lack of ben-
efit from the AO in two different ways:
a) When they used AO to relieve their breathlessness,
it did not make them feel better, or stop them getting
breathless.
b) When going out they were usually sitting on an
electric buggy, or wheelchair, and therefore not exerting
themselves. Thus they did not feel more breathless, so
felt no need to take their AO system out with them.
“Getting no benefit out of it at all, I don’t know that
they (AO cylinders) are making any difference to my
breathing, because I’m still out of breath, and that’s the
problem... I don’t think it’s helping me, we don’t under-
stand why I’m still out of breath”. (Pt9, 5, 150)
It is not known how participants derived their expec-
tations of oxygen as a means of relieving breathlessness,
but even those who had been prescribed long term oxy-
gen for 24 hours per day, did not take AO out with
them.
Twelve of the participants expressed deriving some
benefit from AO but this was related primarily to the
presence of the AO cylinders providing increased feel-
ings of security when outside the home (even when not
in use), rather than relief of breathlessness, or having
increased exercise capacity.
3. Fear: the AO might run out
Cylinders were equipped with a small clock-face dial to
indicate the amount of remaining oxygen using a traffic
light system: green for full (to a half), orange (for one
half-to one quarter full) and red for a quarter full. Prac-
tically, this dial was obscured by the jacket covering the
cylinder, so users had to lift the cylinder out of the
jacket to look at the gauge. Eleven participants
expressed a fear of the cylinder running out of oxygen
when they were away from home.
“I’m worried it’s (AO) going to run out, I can see the
dial going down, so I don’t like to go too far away from
this one (long term oxygen therapy system), in fact it
restricts me in some ways because I can’t go out for
long.” (Pt 13, 5, 137)
Those participants who did not feel that reliability was
a problem were those who had never experienced a
cylinder running out when outside the home.
4. Carers: needing help to use AO outside the house
Only one participant in this sample was able to carry
and use the AO system in the manner envisaged by pre-
scribing health care professionals, which is to take them
out and about in public independently. Carers and per-
sonal transport were fundamental to all other partici-
pants who wished to take AO out of the house with
them. Carers carried the AO to and from the car, or on
and off the electric buggies, and also checked the cylin-
der gauges.
Carer: “She doesn’t think it’s a problem the weight
because she doesn’t carry it, I put it in the car between
us and she uses it as she needs to when we’re going
along. I sort out all the oxygen, we have one in the car
and this one in the house is a back-up. I have to check
them all the time ‘cause she leaves them on” (Pt 3,
8,237)
Four participants in this study had no immediate carer
and relied on relatives, who lived some distance away, to
help them go out. Some of these relatives had difficulties
themselves, which precluded them from helping with an
AO system.
“Well I only go out if my daughter is with me, it’s (AO)
too heavy to use to carry. We get a taxi...my daughter
would have to carry it from the taxi to the wheelchair
but she has been unwell and it’s too much for her.”
(Pt15, 4, 117)
These four participants left the house infrequently.
The absence of an immediate carer meant they had no
means to carry the AO system, and they were unable to
use it outside the home. The one negative case in this
domain is explained at the beginning of this section.
5. Embarrassment: not wishing to be seen using AO
In this sample, embarrassment was a very significant
factor affecting behaviour. Twenty-one participants
complained that they disliked being seen out with an
AO cylinder. Even participants on 24 hour supplemen-
tary oxygen did not use their AO out in public. Feelings
of embarrassment resulted in some counter-intuitive use
of the AO system. For example, several participants
reported using the AO on a car journey to their destina-
tion (for example to shops, or social events) then leaving
the AO in the car while out in public (for example, in
the shop), before resuming the AO use when returning
to the car.
“... it’s just that I feel that people would stare at you
and it would make me feel very uncomfortable” (Pt25, 4,
109)
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“I wouldn’t like people looking at me, I just feel embar-
rassed about it...I think it’s probably me, I have always
been very independent and I don’t like being ill...and I
don’t want other people to know I’m ill” (Pt2, 3, 89)
This was true even for those who had a willing carer
to carry the equipment. Of the participants who were
using AO out of the house, only two did not feel embar-
rassed at using AO in public.
6. Weight: AO is too heavy
Only one participant was carrying his oxygen system out
in the community. Twenty-five of the 27 participants
reported that the weight of the cylinder was a barrier to
use. Participants suggested that carrying the cylinder
would impact negatively on their ability to walk any-
where, and made it more difficult to go outside.
“I mean how on earth are you supposed to lug a great
weight like that around and walk very far, this is my
problem I can walk in here (home) but I can’t walk very
far when I’m out because I’m lugging that, it’s ridiculous,
I have to have someone with me just so I can take that
cylinder.” (Pt27, 3, 96)
“If they could invent something lighter and smaller I’d
give it a go but it’s totally unsuitable for the way I live
my life.” (Pt 20, 4, 217)
There was only one negative case in this domain,
described at the beginning of this section.
Discussion
The main purpose behind ambulatory oxygen provision
is to enable people with COPD to remain mobile and
socially active, while preventing oxygen desaturation.
This research found that problems with the equipment
itself prevented this outcome. Additionally, lack of infor-
mation, stigma and lack of social support all contributed
to the difficulties patients encountered when trying to
use this prescribed medication. One of the most interest-
ing findings was the dissonance between what health pro-
fessionals believe patients are doing, and the reality on
the ground, which was discovered through an in-depth
qualitative approach within the home environment. It
has been argued that non-adherence has less to do with
patient culpability and more to do with failure to con-
sider individuals’ circumstances at the time of prescrip-
tion [15]. In this study, inappropriate ambulatory
equipment had been prescribed to COPD patients, many
of whom were physically unable to use the system. Cylin-
ders were too heavy and cumbersome to carry, and even
if carers were present to assist, they often had their own
medical problems which made using AO virtually impos-
sible. Many participants still enjoyed active social lives,
but found it daunting to use their AO systems in public,
as they feared being perceived as ‘different’ or an ‘invalid’.
The majority solved this dilemma by not using their AO.
The importance of providing specific information to
allow patients to self-manage a chronic condition is well
documented [16]. Patients negotiate their use of medi-
cines in the light of personal need and their daily rou-
tines, and ultimately decide what is right for them; but
education is essential to enable informed decisions.
There is little published literature relating to specific
medical instructions on the use of AO, although Petty
and Bliss state that desaturating patients should use AO
‘whilst walking’ [17]. In our study no participants could
recall receiving specific instructions on AO usage from
health professionals, and so followed a generic instruc-
tion to “use it when you’re out”. The lack of specific
instructions found within this study may reflect a wider
uncertainty within the medical profession as to the opti-
mum prescription of oxygen through a 24 hour period.
Current prescribing is based on trials conducted
30 years ago [18], the conclusions from which have
been questioned [8]. Guidelines for patient information
provision on AO are not currently available. Profes-
sionals need to decide if allowing oxygen delivery per-
sonnel to give patients instructions on the use of AO is
a desirable consequence of not giving more specific
written personalised instructions to AO patients.
In this study those participants who felt they derived
no benefit from AO, did not attempt to use it outside.
Non-adherence to medication because no benefit is per-
ceived has been reported in research into the use of
general medication by COPD patients [7,19,20]. Percep-
tions of benefit are related to expectation, but it is diffi-
cult to establish where and how patients build their
expectations. The provision of specific AO information
would reduce the development of unrealistic expecta-
tions, and should thereby increase perceptions of benefit
and encourage adherence. Alternatively, lack of per-
ceived benefit may result from inappropriate prescrip-
tion (in this sample not all prescriptions followed
assessment in secondary care for specific exertional
desaturation), or through incorrect use of AO.
Fear of the oxygen running out has not been pre-
viously reported in AO research. Technical equipment is
the only way oxygen can be delivered to a patient, and
lack of confidence in the equipment reduced willingness
to go out of the house with the system. A study of 65
diabetic patients has suggested that lack of confidence
in insulin-delivery devices compromised adherence to
medication [21]. In this study, those participants who
thought the gauge was unreliable, and that the cylinder
might run out, perceived this to be a barrier to AO use.
Robust research data on the reliability and accuracy of
oxygen gauges are not available, but anecdotal clinical
information suggests less than optimal accuracy, so
there may be some basis for these participants’ fears.
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Embarrassment was a common theme, confirming
findings from a small qualitative study by Williams et al
who reported that COPD patients described feelings of
embarrassment because of the visibility of their oxygen
equipment [22]. Earnest (2002) also reported that
patients who used oxygen described embarrassment and
self-consciousness when using AO [23]. COPD has very
visual side effects i.e. the patient is seen to be breathless,
coughs aloud, and may need to carry overt medication
(such as AO, metered dose inhalers, or nebulisers) with
them. This marks the patient out as someone who is
different from the rest of the population and has stigma-
tising consequences [24]. Participants in this study
voiced very strong opinions about not wanting to be dif-
ferent, or stand out from the crowd and this influenced
their use of AO outside the home. To date there has
been very little research into stigma in COPD, and how
it may affect behaviour. Social support was essential in
overcoming feelings of embarrassment, and in enabling
participants to overcome the physical barriers to use of
their AO (that is, to carry and maintain the equipment).
Those participants who had no carers and no transport
never used their AO outside the house. Previous
research has suggested that positive social support has a
direct influence on self-care activities and coping skills
in COPD [25], but this is the first description of the
essential role played by carers to enable patients with
COPD to use their AO appropriately.
The negative impact of the weight of AO equipment on
use has been documented by previous researchers [4].
One study looking at adherence levels in long term oxy-
gen therapy for a mixed pathology group found that 58%
of 192 participants were not using the AO outside the
house, with system weight cited as the most important
factor affecting usage [26]. Several studies suggest that
muscle weakness in COPD is a significant co-morbidity
[27] and that therapeutic interventions such as long-term
steroid use may contribute to this muscle weakness [28].
Most of these study participants were over 65 years of
age, and had COPD for several years, which may partly
explain their inability to carry the AO system.
Limitations
Participants in this study all used one type of cylinder AO,
so these findings cannot be generalised to patients using
other types of AO, although clinical observation indicates
that many of the issues raised are similar for patients
using liquid oxygen. All participants were recruited from
one geographical area in the South of the UK, although
there were different AO prescribers within this area.
Implications for future research and clinical practice
If AO is going to fulfil its potential to keep COPD
patients more physically and socially mobile, then
patients require detailed, personalised plans of how and
when to use it. Any desaturating COPD patient should
be given specific instructions on use of AO during activ-
ity. Patients who feel information about medication is
personal to them are more likely to use that medication
[29]. The effect of such specific information provision
on subsequent AO use in the community is an impor-
tant area for future research. Patients need help to find
ways of managing the perceived barriers, particularly if
they have no carers, or have carers who are unable to
help them. Patients also need help to overcome the
embarrassment they feel when using AO out of the
house. This might require psychological support, or
more information as to why they need to use AO.
Patients need more information on why maintaining
their exercise levels is important to their disease process,
even at this supplementary oxygen stage of the COPD
pathway. The NHS standard AO equipment itself could
also be improved, in terms of reducing weight and
increasing portability, reducing its overt ‘medical’ prop-
erties (to reduce stigmatisation), and increasing the
reliability of its gauges.
Conclusions
Grounded theory is designed to produce theory about
the area under study. The theory produced as a result of
this research is that COPD patients who perceive that
AO negatively adds to the physical, mental or social
burden of their condition are unlikely to use their sys-
tem. COPD patients with the NHS standard type of AO
system are unable to use their medication as prescribed
because of the difficulties they experience with the AO
system itself i.e. principally the perceived unreliability of
the gauges and the weight of the system. There is also
considerable embarrassment felt at being seen with an
AO system in public. This highlights the difficulties that
patients face when asked to incorporate medical tech-
nology into their lives and illustrates the pitfalls asso-
ciated with designing technologies without reference to
the ultimate end users. Novel findings in this study were
the lack of specific information provision for those pre-
scribed AO, the fear that the oxygen might run out
(perceived gauge unreliability), and the essential role of
the patients’ carers in managing and maintaining the
AO equipment. It is debatable which of these issues has
greater significance in terms of affecting AO use, but all
of them could be addressed with appropriately designed
interventions involving patient input to improve the
acceptability of existing equipment, to design better
equipment, and to improve the quality of the informa-
tion provided to patients and carers. Attention to each
of these issues may be needed to optimise adherence to
AO prescription and enhance the physical and social
benefits of maintaining mobility in this patient group.
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Additional material
Additional file 1: Semi-structured interview schedule. Examples of
questions used during the interviews with participants
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